The Underlying Mechanism Involved in Gefitinib Resistance and Corresponding Experiment Validation in Lung Cancer

BACKGROUND: Gefitinib resistance remains a major problem in the treatment of lung cancer. However, the underlying mechanisms involved in gefitinib resistance are largely unclear. METHODS: Open-accessed data of lung cancer patients were downloaded from The Cancer Genome Atlas Program and Gene Express...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Puwei, Zhou, Jianghui, Wu, Kaiqin, Wang, Wenli, Gu, Shaorui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188267/
https://www.ncbi.nlm.nih.gov/pubmed/37205010
http://dx.doi.org/10.1155/2023/9658912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188267/
https://www.ncbi.nlm.nih.gov/pubmed/37205010
http://dx.doi.org/10.1155/2023/9658912

Ejemplares similares